It has been announced that the European Patent Office (EPO) has signed an agreement with the government of Georgia to enable European patents to be validated in Georgia.

On 26 November 2020 the German Parliament (Bundestag) passed the bill required for German ratification of the Unified Patent Court Agreement (UPCA) with 570 votes in favour...

Following the passing in Germany of the Bill for Re-ratification of the Unified Patent Court Agreement (UPCA) in December 2020, two constitutional complaints against German ratification were filed...

Today the Federal Council (Bundesrat) unanimously passed the bill required for German ratification of the Unified Patent Court Agreement (UPCA) thereby achieving the two-thirds majority...

Two applications at the German Constitutional Court (FCC) for preliminary injunctions against German ratification of the Unified Patent Court Agreement (UPCA) have been rejected...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium, with effect from 1 January 2021.

On 11 September 2019 Advocate General Hogan issued his Opinion in connection with the combined referrals to the CJEU in Royalty Pharma C-650/17 and Sandoz C-114/18.

We reported earlier this year (see here) that the EPO's Enlarged Board of Appeal has been asked to consider whether the Boards of Appeal can hold oral proceedings in Haar without violating the EPC.

As previously reported, the UK Court of Appeal rejected an attempt to name a computer system (DABUS) as an inventor on a UK patent application.

The High Court has handed down a judgment in the case of Promptu Systems Corporation v Sky UK Limited et al. The case related to the alleged infringement by Sky's Sky Q subscription television service...

As reported previously, the UK government has been consulting on the future regime for exhaustion of intellectual property rights following the UK's departure from the EU.

The Financial Times has revealed the results of its 2020 survey of Europe's patent law firms. This listing is based on recommendations by clients and peers, as compiled by the FT's research partner

The Unified Patent Court (UPC) opened for business in June this year. In this webinar, we will look at how UPC litigation has been shaping up over the first six months, including practical...

We reported in August 2021 that the EPO's Enlarged Board of Appeal (EBA) would be considering the doctrine of plausibility at the EPO.

The World Trade Organization (WTO) has reached a limited agreement to relax patent protections for the production and supply of COVID-19 vaccines.

The EPO has announced that it is extending the use of video conference for opposition division oral proceedings until 31 January 2022.

Protecting valuable plant varieties and plant biotechnological inventions requires a nuanced understanding of the evolving legal environment. With regulatory changes and new legislative proposals...

As we previously reported, the European Commission proposed a new framework concerning Standard Essential Patents (SEPs) and their licencing in April 2023.

The Board of Appeal in T 0439/22 referred questions to the Enlarged Board of Appeal in order to clarify the extent to which the description should be referred to when interpreting the claims.

It has now been over two years since the Enlarged Board issued their decision G2/21 regarding "plausibility", and the conditions under which post-filed data can be taken into account to support a technical effect.